Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjogren's syndrome: follow-up after the end of the phase II open-label BELISS study - Quartuccio, L; Salvin, S; Corazza, L (Clinical and experimental rheumatology, 2016)
et al.